Toxikon's Preclinical In Vivo Services

A Collaborative Approach to Biopharmaceutical and Biotechnology Product Development  

Toxikon provides preclinical in vivo efficacy models for numerous diseases, including oncology, glaucoma and pharmacokinetic, toxicology, genotoxicity services.  We are also poised to customize preclinical pharmacology and consulting services to expedite the development of product.

Toxikon's in vivo services for biotechnology and biopharmaceutical products include:

• Pharmacology
• Toxicology
• Immunotoxicology
• PK/TK

Our In Vivo Department can guide you through this stage of the development process by selecting appropriate animal models, designing sound research practices, conducting high-quality in vivo studies, and generating study reports tailored to your needs.  We understand the importance of collaboration, meeting project timelines, and maintaining control over your budget. By using in vivo contract research services, clients can take advantage of our scientists' many years of preclinical research and project management experience, while saving valuable time and money. Our in vivo facilities are AAALAC International accredited.